Hysterectomy pp 219-232 | Cite as

Uterine Morcellation

  • Courtney J. StellerEmail author
  • Charles E. Miller


Minimally invasive surgical techniques have been proven to lead to decreased post operative pain, decreased morbidity, and faster recovery times when compared to open abdominal procedures. According to committee opinions from ACOG and the AAGL, the preferred route for hysterectomy is a minimally invasive approach, including a laparoscopic or vaginal approach when feasible. Fibroids are the most common indication for a hysterectomy (40.7 %) which in turn makes specimen removal difficult as the specimen size is often larger than the abdominal or vaginal incisions made during surgery. As stated by Wright et al., patients who are nulliparous or have a large uterine size are at higher risk of requiring alternate methods of specimen removal such as morcellation. Morcellation is defined as “division and removal in small pieces” in the Merriam-Webster dictionary. In addition, a similar challenge arises when removing tissue in the absence of a colpotomy, as in a supracervical hysterectomy or myomectomy.


Morcellation Morcellator Hysterectomy Fibroid Leiomyoma Leiomyomata Leiomyosarcoma 


  1. 1.
    Nieboer TE, Johnson N, Lethaby A, Tavender E, Curr E, Garry R, et al. Surgical approach to hysterectomy for benign gynaecological disease. Cochrane Database Syst Rev. 2009;3:CD003677.Google Scholar
  2. 2.
    American College of Obstetrics and Gynecology. Choosing the route of hysterectomy for benign disease. ACOG Committee Opinion Number 444, Nov 2009.Google Scholar
  3. 3.
    Whiteman MK, Hillis SD, Jamieson DJ, et al. Inpatient hysterectomy surveillance in the United States, 2000–2004. Am J Obstet Gynecol. 2008;198:34.e1–7.CrossRefGoogle Scholar
  4. 4.
    Wright JD, Herzog TJ, Tsui J, et al. Nationwide trends in the performance of inpatient hysterectomy in the United States. Obstet Gynecol. 2013;122(2 pt 1):233–41.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Mettler, Liselotte. Letter to the author. 14 May 2015 TS.Google Scholar
  6. 6.
    Semm K. Morcellement and suturing using pelviscopy: not a problem any more [in German]. Geburtshilfe Frauenheilkd. 1991;51:843–6.CrossRefPubMedGoogle Scholar
  7. 7.
    Steiner RA, Wight E, Tadir Y, Haller U. Electrical cutting device for laparoscopic removal of tissue from the abdominal cavity. Obstet Gynecol. 1993;81:471–4.PubMedGoogle Scholar
  8. 8.
    Carter JE, McCarus SD. Laparoscopic myomectomy. time and cost analysis of power vs. manual morcellation. J Reprod Med. 1997;42:383–8.PubMedGoogle Scholar
  9. 9.
    Brucker S, Solomayer E, Zubke W, et al. A newly developed morcellator creates a new dimension in minimally invasive surgery. J Minim Invasive Gynecol. 2007;14:233–9.CrossRefPubMedGoogle Scholar
  10. 10.
    De Grandi P, Chardonnens E, Gerber S. The morcellator knife: a new laparoscopic instrument for supracervical hysterectomy and morcellation. Obstet Gynecol. 2000;95(5):777–8.PubMedGoogle Scholar
  11. 11.
    Zullo F, Falbo A, Iuliano A, et al. Randomized controlled study comparing the Gynecare Morcellex and Rotocut G1 tissue morcellators. J Minim Invasive Gynecol. 2010;17(2):192–9.CrossRefPubMedGoogle Scholar
  12. 12.
    Walid MS, Heaton RL. A large fibroid uterus removed with a bipolar morcellator. Proc Obstet Gynecol. 2011;1(3):11.Google Scholar
  13. 13.
    Milad MP, Milad EA. Laparoscopic morcellator-related complications. J Minim Invasive Gynecol. 2014;21:486–91.CrossRefPubMedGoogle Scholar
  14. 14.
    Streicher L. A gynecologist’s guide to laparoscopic morcellation. Female Patient. 2010;35:26–35.Google Scholar
  15. 15.
    Rosenblatt PL, Makai G, DiSciullo AJ. Laparoscopic supracervical hysterectomy with transcervical morcellation. J Minim Invasive Gynecol. 2010;17:331–6.CrossRefPubMedGoogle Scholar
  16. 16.
    Wang CJ, Yuen LT, Lee CL, Kay N, Soong YK. A prospective comparison of morcellator and culdotomy for extracting of uterine myomas laparoscopically in nullipara. J Minim Invasive Gynecol. 2006;13(5):463–6.CrossRefPubMedGoogle Scholar
  17. 17.
    Larrain D, Rabischong B, Khoo CK, et al. “Iatrogenic” parasitic myomas: unusual late complication of laparoscopic morcellation procedures. J Minim Invasive Gynecol. 2010;17(6):719–24.CrossRefPubMedGoogle Scholar
  18. 18.
    Cucinella G, Granese R, Calagna G, Somigliana E, Perino A. Parasitic myomas after laparoscopic surgery: an emerging complication in the use of morcellator? Description of four cases. Fertil Steril. 2011;96:e90–6.CrossRefPubMedGoogle Scholar
  19. 19.
    Leren V, Langebrekke A, Qvigstad E. Parasitic leiomyomas after laparoscopic surgery with morcellation. Acta Obstet Gynecol Scand. 2012;91:1233–6.CrossRefPubMedGoogle Scholar
  20. 20.
    Donnez O, Squifflet J, Leconte I, Jadoul P, Donnez J. Posthysterectomy pelvic adenomyotic masses observed in 8 cases out of a series of 1405 laparoscopic subtotal hysterectomies. J Minim Invasive Gynecol. 2007;14(2):156–60.CrossRefPubMedGoogle Scholar
  21. 21.
    Kho KA, Nezhat C. Parasitic myomas. Obstet Gyencol. 2009;114:611–5.CrossRefGoogle Scholar
  22. 22.
    Moon HS, Koo JS, Park SH, et al. Parasitic leiomyoma in the abdominal wall after laparoscopic myomectomy. Fertil Steril. 2008;90:e1–2.CrossRefGoogle Scholar
  23. 23.
    Hutchins Jr FL, Reinoehl EM. Retained myoma after laparoscopic supracervical hysterectomy with morcellation. J Am Assoc Gynecol Laparosc. 1998;5:293–5.CrossRefPubMedGoogle Scholar
  24. 24.
    Paul PG, Koshy AK. Multiple peritoneal parasitic myomas after laparoscopic myomectomy and morcellation. Fertil Steril. 2006;85:492–3.CrossRefPubMedGoogle Scholar
  25. 25.
    Ostrzenski A. Uterine leiomyoma particle growing in an abdominal wall incision after laparoscopic retrieval. Obstet Gynecol. 1997;89:853–4.CrossRefPubMedGoogle Scholar
  26. 26.
    Takeda A, Mori M, Sakai K, et al. Parasitic peritoneal leiomyomatosis diagnosed 6 years after laparoscopic myomectomy with electric tissue morcellation: report of a case and review of the literature. J Minim Invasive Gynecol. 2007;14(6):770–5.CrossRefPubMedGoogle Scholar
  27. 27.
    Hardman 3rd WJ, Majmudar B. Leiomyomatosis peritonealis disseminate: clinicopathologic analysis of five cases. South Med J. 1996;89(3):291–4.CrossRefPubMedGoogle Scholar
  28. 28.
    Bisceglia M, Galliani C, Pizzolitto S, et al. Selected case from the Arkadi M. Rywlin International Pathology Slide Series: Leiomyomatosis peritonealis disseminata: report of 3 cases with extensive review of the literature. Adv Anat Pathol. 2014;21(3):201–15.CrossRefPubMedGoogle Scholar
  29. 29.
    Al-Talib A, Tulandi T. Pathophysiology and possible iatrogenic cause of leiomyomatosis peritonealis disseminate. Gynecol Obstet Invest. 2010;69(4):239–44.CrossRefPubMedGoogle Scholar
  30. 30.
    Takeda A, Mori M, Sakai K. Parasitic peritoneal leiomyomatosis diagnosed 6 years after laparoscopic myomectomy with electric tissue morcellation: report of a case and review of the literature. J Minim Invasive Gynecol. 2007;14:770–5.CrossRefPubMedGoogle Scholar
  31. 31.
    Hales HA, Peterson CM, Jones KP, et al. Leiomyomatosis peritonealis disseminate treated with a gonadotropin-releasing hormone agonist. a case report. Am J Obstet Gynecol. 1992;167:515–6.CrossRefPubMedGoogle Scholar
  32. 32.
    Takeda T, Masuhara K, Kamiura S. Successful management of a leiomyomatosis peritonealis disseminate with an aromatase inhibitor. Obstet Gynecol. 2008;112(2 pt2):491–3.CrossRefPubMedGoogle Scholar
  33. 33.
    Sepilian V, Della BC. Iatrogenic endometriosis caused by uterine morcellation during a supracervical hysterectomy. Obstet Gynecol. 2003;102:1125–7.PubMedGoogle Scholar
  34. 34.
    Brown RL. Iatrogenic endometriosis caused by uterine morcellation during a supracervical hysterectomy. Obstet Gynecol. 2004;103:583. , author reply 583–84.CrossRefPubMedGoogle Scholar
  35. 35.
    Decenzo JA. Iatrogenic endometriosis caused by uterine morcellation during a supracervical hysterectomy. Obstet Gynecol. 2004;103:583.CrossRefPubMedGoogle Scholar
  36. 36.
    Schuster MW, Wheller TL, Richter HE. Endometriosis after laparoscopic supracervical hysterectomy with uterine morcellation: a case control study. J Minim Invasive Gynecol. 2012;19(2):183–7.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Pereira N, Buchanan T, Wishall K, et al. Electric morcellation-related reoperations after laparoscopic myomectomy and nonmyomectomy procedures. J Minim Invasive Gynecol. 2014;S1553-4650(14):01292–8.Google Scholar
  38. 38.
    American Association of Gynecologic Laparoscopists. AAGL practice report: Morcellation during uterine tissue extraction. J Minim Invasive Gynecol. 2014;21(4):517–30.CrossRefGoogle Scholar
  39. 39.
    Katz VL, Lentz GM, Lobo RA, Gershenson DM. Comprehensive gynecology. 5th ed. Philadelphia: Mosby; 2007.Google Scholar
  40. 40.
    Gungorduk K, Asicioglu O, Ertas IE, et al. Comparison of the histopathological diagnoses of preoperative dilation and curettage and Pipelle biopsy. Eur J Gynaecol Oncol. 2014;35(5):539–43.PubMedGoogle Scholar
  41. 41.
    Ramm O, Gleason JL, Segal S, Antosh DD, Kenton KS. Utility of preoperative endometrial assessment in asymptomatic women undergoing hysterectomy for pelvic floor dysfunction. In Urogynecol J. 2012;23(7):913–7.CrossRefGoogle Scholar
  42. 42.
    Turner T, Secord AA, Lowery WJ, Sfakianos G, Lee PS. Metastatic adenocarcinoma after laparoscopic supracervical hysterectomy with morcellation: a case report. Gynecol Oncol Case Rep. 2013;5:19–21.CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Hagemann IS, Hagemann AR, LiVolsi VA, Montone KT, Chu CS. Risk of occult malignancy in morcellated hysterectomy: a case series. Int J Gynecol Pathol. 2011;30:476–83.CrossRefPubMedGoogle Scholar
  44. 44.
    Della Badia C, Karini H. Endometrial stromal sarcoma diagnosed after uterine morcellation in laparoscopic supracervical hysterectomy. J Minim Invasive Gynecol. 2010;17:791–3.CrossRefPubMedGoogle Scholar
  45. 45.
    Silverberg SG. Leiomyosarcoma of the uterus. a clinicopathologic study. Obstet Gynecol. 1971 Oct;38(4):613–28.CrossRefPubMedGoogle Scholar
  46. 46.
    Rauh-Hain JA, Oduyebo T, Diver E, et al. Uterine Leiomyosarcoma: an updated series. Int J Gyencol Cancer. 2013;23(6):1036–43.CrossRefGoogle Scholar
  47. 47.
    Berek JS, Hacker NF. Gynecologic oncology. 5th ed. Philadelphia: Lippincott Williams & Wilkens; 2010.Google Scholar
  48. 48.
    Rose PG. Cancer of the uterine corpus. Precis: an update in obstetrics and gynecology. Oncology. 3rd ed. Washington, DC: The American College of Obstetricians and Gynecologists; 2008.Google Scholar
  49. 49.
    Sato K, Yuasa N, Fujita M, et al. Clinical application of diffusion-weighted imaging for preoperative differentiation between uterine leiomyoma and leiomyosarcoma. Am J Obstet Gynecol. 2014;210(4):368.e1–8.CrossRefGoogle Scholar
  50. 50.
    Kitajima K, Murakami K, Kaji Y, et al. Spectrum of FDG PET/CT findings of uterine tumors. AJR Am J Roentgenol. 2010;195(30):737–43.CrossRefPubMedGoogle Scholar
  51. 51.
    Seki K, Hoshihara T, Nagata I. Leiomyosarcoma of the uterus: ultrasonography and serum lactate dehydrogenase level. Gynecol Obstet Invest. 1992;33:114–8.CrossRefPubMedGoogle Scholar
  52. 52.
    Goto A, Takeuchi S, Sugimura K, Maruo T. Usefulness of Gd-DTPA contrast-enhanced dynamic MRI and serus determination of LDH and its isozymes in the differential diagnosis of leiomyosarcoma from degenerated leiomyoma of the uterus. Int J Gynecol Cancer. 2002;12(4):354–61.CrossRefPubMedGoogle Scholar
  53. 53.
    Stine JE, Clarke-Pearson DL, Gehrig PA. Uterine morcellation at the time of hysterectomy: techniques, risks, and recommendations. Obstet and Gynecol Surv. 2014;69(7):415–25.CrossRefGoogle Scholar
  54. 54.
    US Food and Drug Administration. Laparoscopic uterine power morcellation in hysterectomy and myomectomy: FDA safety communication. Nov 2014.Google Scholar
  55. 55.
    Park JY, Park SK, Kim DY, Kim JH, Kim YM, Kim YT, et al. The impact of tumor morcellation during surgery on the prognosis of patients with apparently early uterine leiomyosarcoma. Gynecol Oncol. 2011;122:255–9.CrossRefPubMedGoogle Scholar
  56. 56.
    Einstein MH, Barakat RR, Chi DS, Sonoda Y, Alektiar KM, Hensley ML, et al. Management of uterine malignancy found incidentally after supracervical hysterectomy or uterine morcellation for presumed benign disease. Int J Gynecol Cancer. 2008;18:1065–70.CrossRefPubMedGoogle Scholar
  57. 57.
    George S, Barysauskas C, Serrano C, Oduyebo T, JA R-H, et al. Retrospective cohort study evaluating the impact of intraperitoneal morcellation on outcomes of localized uterine leiomyosarcoma. Cancer. 2014;120(20):3154–8. [Epub ahead of print].CrossRefPubMedGoogle Scholar
  58. 58.
    Oduyebo T, Rauh-Hain AJ, Meserve EE, et al. The value of re-exploration in patients with inadvertently morcellated uterine sarcoma. Gynecol Oncol. 2014;132:360–5.CrossRefPubMedGoogle Scholar
  59. 59.
    Pritts EA, Parker WH, Brown J, Ollive DL. Outcome of occult uterine leiomyosarcoma after surgery for presumed uterine fibroids: a systematic review. J Minim Invasive Gynecol. 2014;2 [epub ahead of print].Google Scholar
  60. 60.
    Siedhoff MT, Wheeler SB, Rutstein SE, et al. Laparoscopic hysterectomy with morcellation vs abdominal hysterectomy for presumed fibroid tumors in premenopausal women: a decision analysis. Am J Obstet Gynecol. 2015;212:591.PubMedPubMedCentralGoogle Scholar
  61. 61.
    SGO Position Statement: Morcellation. Dec 2013. Accessed 10/2014.
  62. 62.
    Brown, Jubilee and board of trustees. AAGL statement to the FDA on power morcellation. 2014.
  63. 63.
    Cohen SL, Einarsson JI, Wang KC, Brown D, Boruta D, Scheib SA, Fader AN, Shibley T. Contained power morcellation within an insufflated isolation bag. Obstet Gynecol. 2014 Sep;124(3):491–7.CrossRefPubMedGoogle Scholar
  64. 64.
    American College of Obstetricians and Gynecologists. Power morcellation and occult malignancy in gynecologic surgery. A Special Report. May 2014.Google Scholar

Copyright information

© Springer International Publishing Switzerland 2018

Authors and Affiliations

  1. 1.Minimally Invasive Gynecologic Surgery, Obstetrics and GynecologyAdvocate Lutheran General HospitalPark RidgeUSA
  2. 2.Department of Obstetrics & GynecologyUniversity of Illinois at ChicagoChicagoUSA
  3. 3.Minimally Invasive Gynecologic SurgeryAdvocate Lutheran General HospitalPark RidgeUSA
  4. 4.The Advanced Gynecologic Surgery InstituteNapervilleUSA

Personalised recommendations